You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PCWG3

Showing 26 - 50 of 434
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Enfortumab vedotin
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 24, 2023

Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

Recruiting
  • Prostate Cancer
  • Prostate Cancer Metastatic
  • La Jolla, California
  • +1 more
Feb 2, 2023

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

Not yet recruiting
  • Advanced Prostate Cancer
  • Lyon, France
  • +2 more
Oct 18, 2023

Advanced Solid Tumor Trial (ISM3091)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jun 27, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 8, 2023

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Advanced Prostate Cancer Trial in United Kingdom, United States (HPN424)

Active, not recruiting
  • Advanced Prostate Cancer
  • HPN424 In Part 1 (Dose Escalation)
  • HPN424 In Part 2 (Dose Expansion)
  • Los Angeles, California
  • +14 more
Jan 20, 2023

Castrate-Resistant Prostate Cancer Trial in Shanghai (LIGHT-PSMA-CART cells)

Suspended
  • Castrate-Resistant Prostate Cancer
  • LIGHT-PSMA-CART cells
  • Shanghai, Shanghai, China
    Changhai Hospital
Jan 25, 2023

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in Worldwide (acapatamab, Pembrolizumab, Etanercept)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • Campbell, California
  • +29 more
Dec 6, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Shanghai (Fluzoparib, Enzalutamide OR abiraterone acetate With

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 23, 2022

Metastatic Castration Resistant Prostate Cancer Trial in China (AC176)

Not yet recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Beijing, China
  • +4 more
Jan 4, 2023

Prostate Cancer Trial in Sapporo city, Kanazawa-city (177Lu-PSMA-617, 68Ga-PSMA-11, Best supportive/best standard of care)

Recruiting
  • Prostate Cancer
  • 177Lu-PSMA-617
  • +2 more
  • Kashiwa, Chiba, Japan
  • +6 more
Jan 23, 2023

Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Atlanta (VLP-encapsulated TLR9 Agonist CMP-001,,

Not yet recruiting
  • Metastatic Prostate Adenocarcinoma
  • Stage IV Prostate Cancer AJCC v8
  • VLP-encapsulated TLR9 Agonist CMP-001,
  • Nivolumab
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 26, 2022

Prostate Cancer Metastatic Trial in Spain (Olaparib)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Santiago De Compostela, A Coruña, Spain
  • +7 more
Feb 8, 2022

Prostate Cancer Trial in United States (Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone))

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Miami, Florida
  • +4 more
Dec 14, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2023

Prostate Cancer, Refractory Cancer, Castration Resistant Prostatic Cancer Trial in Winston-Salem (Omeprazole 80 mg twice daily)

Recruiting
  • Prostate Cancer
  • +2 more
  • Omeprazole 80 mg twice daily
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Abemaciclib, Atezolizumab)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 26, 2022

Metastatic Castration-resistant Prostate Tumors Trial in Australia, Korea, Republic of, United States (JNJ-78278343, Cetrelimab)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Neoplasms
  • Sarasota, Florida
  • +7 more
Apr 6, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in United States

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Duarte, California
  • +22 more
Jan 3, 2023

Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev

Recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • Stereotactic body radiotherapy
  • +3 more
  • Herlev, Capital Region, Denmark
    Department of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022

Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

Not yet recruiting
  • Cancer
  • [177Lu]Lu-PSMA I&T
  • Meldola, Forlì, Italy
  • +1 more
May 10, 2023

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,

Active, not recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • Duarte, California
  • +26 more
Aug 3, 2022

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023